It is a cytogenetic technique that is used to detect/localize DNA sequneces on chromosomes. Flourescent in-situ Hybridization (FISH) is a big word, to understand it better, let’s...
Position of The CML Society of Canada Regarding the Issue of Generic imatinib in Canada On April 2, 2013 Health Canada approved two generic versions of imatinib...
GLEEVEC® is indicated for the treatment of adult and pediatric patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (CML) in chronic phase. GLEEVEC® is also indicated...
Raising Awareness was our Key Motivator! There are about 5,100 Canadians living with CML. Every day someone in Canada is diagnosed with CML Although we have made...
We are excited to announce that there is another new option that will soon be available for Canadian CML patients in Canada. Pending Pan Canadian Oncology Drug...
ICLUSIG ™ ICLUSIG ™ (Ponatinib) is indicated for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Philadelphia...
Import Expert Panel advice for CML Patients: Advice for people with chronic myeloid leukemia on COVID-19The iCMLf is sharing an expert statement specifically for chronic phase CML...
Notice regarding independent patient activities linked to the generic imatinib mesylate issue: The CML Society of Canada does not endorse or condone independent patient activity that is...
Novartis Pharmaceuticals Canada Inc. (Novartis) has received approval from Health Canada for PrJAKAVI® (ruxolitinib tablets), a drug for the treatment of disease-related splenomegaly (enlarged spleen) and/or its...
Self advocating allows the knowledgeable CML patient to become a highly engaged patient. Studies have shown that engaged patients may have a higher success rate of achieving...
Muchas gracias por tomarse el tiempo para completar la encuesta! Importancia de esta investigación Esta investigación es importante porque ayuda a mejorar nuestra comprensión de la experiencia...
Like CML, Myelofibrosis (MF) is another rare disorder in the family of Myeloproliferative Neoplasms (MPN’s). The CML Society of Canada is expanding our reach to provide support to...
Overview Myelofibrosis (MF) is a life-threatening blood cancer associated with progressive, debilitating symptoms that can severely impact quality of life and shorten survival.[i],[ii] MF is characterized by...
provincial coverage Click on the map below for information regarding government reimbursement in your province. Other coverage Private Insurance Special Access Programs Clinical trial Alberta Jakavi (ruxolitinib) Company:...
We are a strong team of innovative, strategically minded and knowledgeable patients. We have used our talents to create some innovative tools and awareness campaigns to improve...
Today, Health Canada took an important step forward in an effort to bring a National Pharmacare program to all Canadians. The long awaited for, and necessary changes,...
The CML Society of Canada, along with our partners, are pleased to announce the launch of our latest Patient Navigational Tool PCR TRACKER – Specifically engineered for...
Polymerase Chain Reaction (PCR) It is a scientific technique from the branch of molecular biology that allows us to amplify DNA segments. We think it is much...
This study concerns quality of life in patients with myelofibrosis. Information about how myelofibrosis and its treatment affect the lives of patients is important to help doctors...
